InvestorsHub Logo
Followers 17
Posts 3258
Boards Moderated 0
Alias Born 12/03/2009

Re: LaFortuna post# 25695

Saturday, 05/26/2018 10:55:52 AM

Saturday, May 26, 2018 10:55:52 AM

Post# of 111075
CEO Timothy Warbington.. Contrary to many conventional biotechnology firms that may rely on the sale of intellectual property and patents as a financial exit strategy only after many years of clinical trials and subject to FDA approval, Creative Medical’s multifaceted business model, specific acquisitions and product development are intended to create a cash flow which shall provide an attractive return to its shareholders and provide the resources for expansion, acquisitions and development of cutting edge technology in the areas of stem cell technology and nutraceuticals.

https://www.linkedin.com/in/timothy-warbington-90441150


All posts are speculative and my opinion only. NOT investment advice.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News